WSOU Investments LLC v. F5 Networks Inc

District Court, W.D. Washington·Decided June 27, 2022·No. 2:21-cv-00125·Unknown

Opinion

1 UNITED STATES DISTRICT COURT 2 WESTERN DISTRICT OF WASHINGTON 3 AT SEATTLE 4 5 WSOU INVESTMENTS, LLC d/b/a BRAZOS LICENSING AND No. 2:20-cv-1878-BJR 6 DEVELOPMENT, No. 2:21-cv-124-BJR No. 2:21-cv-125-BJR 7 Plaintiff, No. 2:21-cv-126-BJR 8 v.

9 F5 NETWORKS, INC., ORDER ON DISCOVERY DISPUTES AND MOTION TO MODIFY CASE 10 Defendant. SCHEDULE 11

12 Before the Court are a number of pending matters relating to discovery in these consolidated 13 cases relating to discovery. The matters include: (1) written submissions by the parties on various 14 discovery disputes (Dkt. Nos. 149 and 156); (2) Plaintiff’s motion to modify the case schedule (Dkt. 15 No. 171); (3) Plaintiff’s motion to compel (Dkt. No. 178); (4) Defendant’s motion to compel (Dkt. 16 No. 163); (5) Plaintiff’s motion for leave to amend its infringement contentions (Dkt. No. 143); (6) 17 Plaintiff’s motion for leave to supplement the amendments to its infringement contentions (Dkt. 18 19 No. 166; and (7) several motions to seal materials filed in connection with these motions (Dkt. Nos. 20 173, 177, 184, 191, 208, 212, 215). 21 I. BACKGROUND ON DISCOVERY DISPUTES 22 On September 30, 2021, the Court held a teleconference with the parties to discuss their 23 voluminous, never-ending discovery disputes. Dkt. No. 83 (transcript of hearing). The following 24 day, the Court issued a minute order that memorialized the Court’s rulings as follows: 25 Defendant is directed to make a document production in response to Plaintiff’s document 26 requests and interrogatories by October 15, 2021. The production shall be limited to those 27 documents relevant to the Accused Products, as defined in Plaintiff’s document requests and interrogatories, and shall include all documents relevant to said Accused 1 Products. The production need not, at this time, extend to other related products. Defendant has agreed to provide the names of persons with relevant knowledge who will be 2 available for depositions. The parties shall meet and confer on October 4, 2021 at a mutually agreeable time to discuss any remaining issues . . . . 3

4 Dkt. No. 76 (emphasis added). 5 The transcript of the hearing indicates that the Court told Plaintiff’s counsel that its 6 discovery requests were “clearly overbroad” and that Plaintiff could not seek discovery about 7 “related products,” but had to be specific as to how the discovery requirements were relevant to the 8 accused products. Dkt. No. 83 at 19. 9 To say the parties continued to have ongoing disagreements about discovery is a mastery of 10 11 understatement. On November 4, 2021, the Court issued a minute order declining to set another 12 hearing related to discovery, noting that Defendant was still in the process of producing documents 13 and making individuals available for depositions. Dkt. No. 85. The Court indicated that it 14 “expect[ed] the parties to continue to engage in good faith discussions and attempt to resolve their 15 disagreements without Court intervention” and directed the parties to file a joint status report, no 16 longer than five pages, describing their remaining disputes. Id. The parties filed their joint status 17 report on November 17, 2021.1 On December 20, 2021, the parties filed an amended joint status 18 19 report with additional disputes that had arisen. Dkt. No. 114. 20 On February 8, 2022, the Court issued a minute order directing the parties to provide written 21 submissions consolidating the discovery disputes that were pending at the time. Dkt. No. 140. 22 Plaintiff filed its submission on February 14, 2022 (Dkt. Nos. 148, 149), and attached a declaration 23 and exhibits totaling 276 pages (Dkt. No. 151). Defendant filed its response on February 18, 2022 24 25

26 1 In keeping with their practice of increasing the volume and complexity of their discovery issues, the parties’ joint status report was single-spaced rather than double-spaced, which effectively doubled the length of the 27 document that the Court expected. Dkt. No. 97. 1 (Dkt. Nos. 156, 157) and attached a declaration and exhibits totaling 69 pages (Dkt. No. 155). The 2 parties’ written submissions also cross-reference many previously filed documents and hearings. 3 Shortly thereafter, each party filed separate motions to compel covering the same or similar issues. 4 Dkt. Nos. 163, 178. 5 II. LEGAL STANDARD 6 In determining whether to grant or deny the requested discovery, the Court looks to the law 7 8 of the Ninth Circuit rather than the law of the Federal Circuit. See, e.g., Autogenomics, Inc. v. 9 Oxford Gene Tech. Ltd., 566 F.3d 1012, 1021 (Fed. Cir. 2009) (noting that a district court’s ruling 10 on denial of discovery is an issue not unique to patent law and is governed by the law of the district 11 court’s regional circuit); Dorf & Stanton Commc’ns, Inc. v. Molson Breweries, 100 F.3d 919 (Fed. 12 Cir. 1996) (noting that orders compelling discovery are not unique to patent law, and therefore the 13 law of the regional circuit law applies). 14 “Upon a motion to compel discovery, the movant has the initial burden of demonstrating 15 16 relevance. In turn the party opposing discovery has the burden of showing that discovery should 17 not be allowed, and also has the burden of clarifying, explaining, and supporting its objections with 18 competent evidence.” U.S. v. McGraw-Hill Cos., 2014 WL 1647385, at *8 (C.D. Cal. Apr. 15, 19 2014) (citations and internal quotation marks omitted). 20 III. DISCUSSION 21 A. Plaintiff’s Discovery Requests 22 Plaintiff’s written submission requests that the Court compel Defendant to produce 23 24 discovery on a wide range of issues. The Court addresses each issue in turn below. 25 26 27 1 1. Discovery on the Components the Accused Products Used to Achieve Their Accused Functionalities and on Virtual and Cloud Editions of F5’s BIG-IP and 2 VIPRION Platforms 3 Plaintiff requests that the Court compel discovery on “the full scope of accused products, 4 including, but not limited to, producing source code and other responsive documents and 5 information and designating 30(b)(6) witnesses to testify about (1) components that the accused 6 products use to achieve their accused functionalities, including TMOS, iRules, Analytics, iApps, 7 8 iControl, iCall, Container Connector, iQuery, Big-IP Monitors and MRF; and (2) virtual and cloud 9 editions of F5’s BIG-IP and VIPRION platforms.” Dkt. No. 149 at 7. Defendant responds that 10 Plaintiff is improperly seeking discovery on products that were not accused of infringement under 11 Plaintiff’s preliminary infringement contentions. 12 These discovery requests are closely intertwined with Plaintiff’s motions to amend its 13 infringement contentions, which seek to add these same products to the list of accused products. 14 The Court will consolidate ruling on this aspect of the parties’ discovery dispute with the Court’s 15 16 ruling on Plaintiff’s motions to amend. 17 2. F5’s Production of Source Code 18 Plaintiff offers numerous complaints about Defendant’s production of source code. 19 Specifically, Plaintiff maintains: 20 • Defendant “has not produced any source code for the following software features that 21 the accused products use to achieve their accused functionalities, even though all were 22 identified in WSOU’s PICs [Preliminary Infringement Contentions]: traffic detection 23 24 function (TDF), content injection, logging (IPFIX, syslog, HSL), or BIG-IP Video 25 Delivery Optimization, and the software that is preinstalled in BIG-IP and Viprion.” 26 Dkt. No. 149 at 7. 27 • Defendant has not produced the source code for “BIG-IP- Acceleration.” Id. 1 • Defendant’s production of source code for the accused SDC product was incomplete. 2 Id.

Free access — add to your briefcase to read the full text and ask questions with AI

WSOU Investments LLC v. F5 Networks Inc, (W.D. Wash. 2022).

WSOU Investments LLC v. F5 Networks Inc (WSOU Investments LLC v. F5 Networks Inc) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Autogenomics, Inc. v. Oxford Gene Technology Ltd.
566 F.3d 1012 (Federal Circuit, 2009)
Romero v. Allstate Insurance
271 F.R.D. 96 (E.D. Pennsylvania, 2010)